Package 67457-210-05

Brand: cidofovir

Generic: cidofovir anhydrous
NDC Package

Package Facts

Identity

Package NDC 67457-210-05
Digits Only 6745721005
Product NDC 67457-210
Description

1 VIAL, GLASS in 1 CARTON (67457-210-05) / 5 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2013-06-03
Brand cidofovir
Generic cidofovir anhydrous
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "e7774227-c6ba-439d-a32f-01b67d010fc5", "openfda": {"unii": ["JIL713Q00N"], "rxcui": ["199388"], "spl_set_id": ["56541229-8c1a-4550-8951-2415ed08e7e9"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (67457-210-05)  / 5 mL in 1 VIAL, GLASS", "package_ndc": "67457-210-05", "marketing_start_date": "20130603"}], "brand_name": "CIDOFOVIR", "product_id": "67457-210_e7774227-c6ba-439d-a32f-01b67d010fc5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog [EXT]"], "product_ndc": "67457-210", "generic_name": "Cidofovir Anhydrous", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CIDOFOVIR", "active_ingredients": [{"name": "CIDOFOVIR", "strength": "75 mg/mL"}], "application_number": "ANDA201276", "marketing_category": "ANDA", "marketing_start_date": "20130603", "listing_expiration_date": "20261231"}